Clinomics Clinomics (주식회사 클리노믹스) is a biotechnology company that provides genome-based cancer and disease diagnostic solutions. | ![]() Interpace Diagnostics Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies. | ![]() Opko Health Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics. | ![]() MorphoSys MorphoSys is a biotechnology company focused on the research and development of fully human antibodies. | |
Founding Date | Founding Date 2011 | Founding Date 1987 | Founding Date 2007 | Founding Date 1992 |
Type | Type Public | Type Public | Type Public | Type Subsidiary |
Tags | ||||
Locations | Locations HQ | Locations Parsippany-Troy Hills, US HQ Morrisville, US Pittsburgh, US | Locations Miami, US HQ Woburn, US | Locations Planegg, DE HQ Boston, US |
Employees | Employees N/A | Employees 8919% increase | Employees 6,0967% increase | Employees 464 |
Valuation ($) | Valuation ($) N/A | Valuation ($) 11.5 m | Valuation ($) 1.1 b | Valuation ($) N/A |
Financial | ||||
Revenue (est.) | Revenue (est.) ₩8.5b (FY, 2024) | Revenue (est.) $38.7m (FY, 2025) | Revenue (est.) $606.9m (FY, 2025) | Revenue (est.) €238.3m (FY, 2023) |
Cost of goods | Cost of goods ₩7.7b (FY, 2024) | Cost of goods $14.6m (FY, 2025) | Cost of goods $400.9m (FY, 2025) | Cost of goods €34.6m (FY, 2023) |
Gross profit | Gross profit ₩2b (FY, 2024) | Gross profit $24.1m (FY, 2025) | Gross profit $205.9m (FY, 2025) | Gross profit €205.5m (FY, 2023) |
Net income | Net income (₩47.1b) (FY, 2024) | Net income $24.6m (FY, 2025) | Net income ($225.7m) (FY, 2025) | Net income (€189.7m) (FY, 2023) |
Funding | ||||
Total funding raised | Total funding raised N/A | Total funding raised N/A | Total funding raised $ 31m | Total funding raised $ 126m |

Interpace Diagnostics is a health care commercialization company providing insight-driven, integrated multi-channel message delivery for health care companies.
View company
Opko Health engages in the discovery and development of novel and proprietary technologies for pharmaceuticals and diagnostics.
View company
MorphoSys is a biotechnology company focused on the research and development of fully human antibodies.
View company